DJIA 17,082.47 -4.16 -0.02%
NASDAQ 4,473.45 -0.24 -0.01%
S&P 500 1,986.06 -0.95 -0.05%
market minute promo

Pfizer (NYSE: PFE)

30.35 -0.05 (-0.15%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

PFE $30.35 -0.15%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $30.37
Previous Close $30.39
Daily Range $30.34 - $30.57
52-Week Range $27.76 - $32.96
Market Cap $193.6B
P/E Ratio 18.53
Dividend (Yield) $1.04 (3.4%)
Ex-Dividend Date
Dividend Pay Date
07/30/14
09/03/14
Volume 9,164,631
Average Daily Volume 23,070,991
Current FY EPS $2.25

Sector

Healthcare

Industry

Drugs

Pfizer (PFE) Description

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra. Website: http://www.pfizer.com/

News & Commentary Rss Feed

Buyout Blunders: 5 Firms That Should've Said Yes to the Deals

Eli Lilly Beats on Q2 Earnings & Revs, Maintains View - Analyst Blog

IYH, PFE, ABBV, BIIB: Large Outflows Detected at ETF

JNJ: Another Win Added To The Earnings Season

Did Pfizer Make A Horrible Business Deal?

Dodge & Cox Second Quarter 2014 Commentary

Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog

Puma Biotech Surges on Positive Results on Neratinib - Analyst Blog

Cubist Misses Q2 Earnings Estimates on Weak Cubicin Sales - Analyst Blog

Closing Update: Blue Chips Decline But Broader Indices Extend Gains On Mostly Positive Earnings Resu

Closing Update: Blue Chips Decline But Broader Indices Extend Gains On Mostly Positive Earnings Results

Sector Update: Health Care Stocks Mostly Higher Near Bell; Vascular Solutions Up Almost 10% After Q2

Sector Update: Health Care Stocks Mostly Higher Near Bell; Vascular Solutions Up Almost 10% After Q2 EPS Beat, Q3 Outlook

Roche Earnings Preview: Continued Adoption For Key Cancer Drugs Will Drive Growth

See More PFE News...

PFE's Top Competitors

PFE $30.35 (-0.15%)
Current stock: PFE
JNJ $102.14 (-0.05%)
Current stock: JNJ
ROG $60.57 (-2.31%)
Current stock: ROG
GSK $50.13 (0.17%)
Current stock: GSK